The E1a Adenoviral Gene Upregulates the Yamanaka Factors to Induce Partial Cellular Reprogramming
Gracia Mendoza,
Rebeca González-Pastor,
Juan Miguel Sánchez,
Altamira Arce-Cerezo,
Miguel Quintanilla,
Gema Moreno-Bueno,
Anna Pujol,
Carolina Belmar-López,
Alba de Martino,
Efrén Riu,
Tristan A. Rodriguez,
Pilar Martin-Duque
Affiliations
Gracia Mendoza
Instituto Aragonés de Ciencias de la Salud (IACS), 50009 Zaragoza, Spain
Rebeca González-Pastor
Instituto Aragonés de Ciencias de la Salud (IACS), 50009 Zaragoza, Spain
Juan Miguel Sánchez
National Heart and Lung Institute, Imperial College London, London W12 ONN, UK
Altamira Arce-Cerezo
Centro de Biotecnología Animal y de Terapia Génica (CBATEG), Universidad Autónoma de Barcelona, 08193 Bellaterra, Spain
Miguel Quintanilla
Departamento de Bioquímica, Instituto de Investigaciones Biomédicas ‘Alberto Sols’, Universidad Autónoma de Madrid (UAM), (UAM-CSIC), 28029 Madrid, Spain
Gema Moreno-Bueno
Departamento de Bioquímica, Instituto de Investigaciones Biomédicas ‘Alberto Sols’, Universidad Autónoma de Madrid (UAM), (UAM-CSIC), 28029 Madrid, Spain
Anna Pujol
Centro de Biotecnología Animal y de Terapia Génica (CBATEG), Universidad Autónoma de Barcelona, 08193 Bellaterra, Spain
Carolina Belmar-López
Instituto Aragonés de Ciencias de la Salud (IACS), 50009 Zaragoza, Spain
Alba de Martino
Instituto Aragonés de Ciencias de la Salud (IACS), 50009 Zaragoza, Spain
Efrén Riu
Centro de Biotecnología Animal y de Terapia Génica (CBATEG), Universidad Autónoma de Barcelona, 08193 Bellaterra, Spain
Tristan A. Rodriguez
National Heart and Lung Institute, Imperial College London, London W12 ONN, UK
Pilar Martin-Duque
Instituto Aragonés de Ciencias de la Salud (IACS), 50009 Zaragoza, Spain
The induction of pluripotency by enforced expression of different sets of genes in somatic cells has been achieved with reprogramming technologies first described by Yamanaka’s group. Methodologies for generating induced pluripotent stem cells are as varied as the combinations of genes used. It has previously been reported that the adenoviral E1a gene can induce the expression of two of the Yamanaka factors (c-Myc and Oct-4) and epigenetic changes. Here, we demonstrate that the E1a-12S over-expression is sufficient to induce pluripotent-like characteristics closely to epiblast stem cells in mouse embryonic fibroblasts through the activation of the pluripotency gene regulatory network. These findings provide not only empirical evidence that the expression of one single factor is sufficient for partial reprogramming but also a potential mechanistic explanation for how viral infection could lead to neoplasia if they are surrounded by the appropriate environment or the right medium, as happens with the tumorogenic niche.